BoBCaT
Completed
293 enrolled
IP4-CHRONOS
Phase NA Completed
100 enrolled 23 charts
SELECT
Active not recruiting
707 enrolled
Evaluation of NanoDoce® in Participants With Urothelial Carcinoma
Phase 1/2 Completed
36 enrolled 18 charts
DART
Phase 3 Terminated
48 enrolled
SHIP0804
Phase 3 Completed
421 enrolled
Effect and Prognosis of Immunohistochemical Biomarkers Changes in Patients With Bladder Cancer After Neoadjuvant Chemotherapy
Unknown
60 enrolled
AADLPC
Phase 3 Completed
362 enrolled 17 charts
Multi-parameter Magnetic Resonance Imaging Guides Precise Treatment of Urothelial Carcinoma
Phase NA Recruiting
100 enrolled
Neoadjuvant Chemotherapy in Non Muscle Invasive T1b Bladder Cancer
Unknown
50 enrolled
Toremifene Followed by Radical Prostatectomy in Treating Patients With Stage I or Stage II Prostate Cancer
Phase 2 Completed
45 enrolled
Sunitinib Before and After Surgery in Treating Patients With Metastatic Kidney Cancer That Can Be Removed By Surgery
Phase 1 Terminated
17 enrolled
Sunitinib and Surgery in Treating Patients With Localized or Metastatic Kidney Cancer
Phase NA Completed
20 enrolled 6 charts
GM-CSF Before Surgery in Treating Patients With Localized Prostate Cancer
Phase 1 Completed
24 enrolled
Chemotherapy Before and After Surgery in Treating Children With Wilm's Tumor
Phase 3 Unknown
350 enrolled
Soy Isoflavones in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage I or Stage II Adenocarcinoma of the Prostate
Phase 2 Completed
32 enrolled
Sunitinib Before and After Surgery in Treating Patients With Stage IV Kidney Cancer
Phase 2 Unknown
20 enrolled
Sunitinib Before or After Surgery in Treating Patients With Metastatic Kidney Cancer
Phase 2 Unknown
110 enrolled
Cisplatin, Gemcitabine Hydrochloride, and Sorafenib Tosylate in Treating Patients With Transitional Cell Cancer of the Bladder
Phase 2 Unknown
45 enrolled
Celecoxib and Rosiglitazone in Treating Patients Who Are Undergoing Cystoscopic Surveillance for Early-Stage Noninvasive Carcinoma of the Bladder or Radical Cystectomy for Muscle-Invasive Carcinoma of the Bladder
Phase NA Withdrawn
Neoadjuvant Exisulind in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage II or Stage III Prostate Cancer
Phase 2 Completed
130 enrolled
S0121, Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplatin and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Carcinoma of the Urothelium
Phase 2 Completed
7 enrolled
Neoadjuvant CCI-779 Followed By Radical Prostatectomy in Treating Patients With Newly Diagnosed Prostate Cancer Who Have a High Risk of Relapse
Phase 2 Completed
15 enrolled
Leuprolide, Bicalutamide, and Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer After External-Beam Radiation Therapy
Phase 2 Completed
50 enrolled
Neoadjuvant Ifosfamide, Doxorubicin, Gemcitabine, and Cisplatin in Treating Patients Who Are Undergoing Radical Cystectomy for Locally Advanced Carcinoma (Cancer) of the Urothelium
Phase 2 Completed
65 enrolled
Irinotecan and Cisplatin in Treating Patients With Locally Advanced or Metastatic Penile Cancer
Phase 2 Completed
Hormone Therapy With or Without Squalamine Lactate in Treating Patients Who Are Undergoing a Radical Prostatectomy for Locally Advanced Prostate Cancer
Phase 2 Withdrawn
Neoadjuvant Chemotherapy Plus Nephroureterectomy for Locally Advanced Upper Tract Transitional Cell Cancer
Phase 2 Withdrawn